Transactions of the Royal Society of Tropical Medicine and Hygiene
Volume 102, Issue 10 , Pages 983-989 , October 2008

Loiasis: African eye worm

Received 24 January 2008 ,Revised 26 March 2008 ,Accepted 26 March 2008.

References 

  1. Agbolade OM, Akinboye DO. Detection of microfilariae with counting chamber technique in some Nigerian rural communities. Afr. J. Biotechnol. 2005;4:367–370
  2. Agbolade OM, Akinboye DO, Ogunkolo O. Loa loa and Mansonella perstans: neglected human infections that need control in Nigeria. Afr. J. Biotechnol. 2005;4:1554–1558
  3. Akue JP, Hommel M, Devaney E. Markers of Loa loa infection in permanent residents of a loiasis endemic area of Gabon. Trans. R. Soc. Trop. Med. Hyg. 1996;90:115–118
  4. Anosike JC, Nwoke BE, Onwuliri CO, Obiukwu CE, Duru AF, Nwachukwu MI, et al. Prevalence of parasitic diseases among nomadic Fulanis of south-eastern Nigeria. Ann. Agric. Environ. Med. 2004;11:221–225
  5. Barua P, Barua N, Hazarika NK, Das S. Loa loa in the anterior chamber of the eye: a case report. Indian J. Med. Microbiol. 2005;23:59–60
  6. Boussinesq M. Loiasis. Ann. Trop. Med. Parasitol. 2006;100:715–731
  7. Boussinesq M, Gardon J. Prevalences of Loa loa microfilaraemia throughout the area endemic for the infection. Ann. Trop. Med. Parasitol. 1997;91:573–589
  8. Boussinesq M, Gardon J. Challenges for the future: loiasis. Ann. Trop. Med. Parasitol. 1998;92(Suppl. 1):S147–S151
  9. Boussinesq M, Gardon J, Kamgno J, Pion SD, Gardon-Wendel N, Chippaux JP. Relationships between the prevalence and intensity of Loa loa infection in the Central province of Cameroon. Ann. Trop. Med. Parasitol. 2001;95:495–507
  10. Boussinesq M, Gardon J, Gardon-Wendel N, Chippaux JP, Chippaux P. Clinical picture, epidemiology and outcome of Loa-associated serious adverse events related to mass ivermectin treatment of onchocerciasis in Cameroon. Filaria J. 2003;2(Suppl. 1):S4
  11. Bradley M, Kumaraswami V. Essential tools—drugs and clinical drug trials. Am. J. Trop. Med. Hyg. 2004;71(Suppl. 5):7–11
  12. CDC, 2004. DPDx: laboratory identification of parasites of public health concern. US Centers for Disease Control and Prevention. http://www.dpd.cdc.gov/dpdx [accessed 21 January 2008].
  13. Cheke RA, Mas J, Chainey JE. Potential vectors of loiasis and other tabanids on the island of Bioko, Equatorial Guinea. Med. Vet. Entomol. 2003;17:221–223
  14. Chippaux JP, Ernould JC, Gardon J, Gardon-Wendel N, Chandre F, Barberi N. Ivermectin treatment of loiasis. Trans. R. Soc. Trop. Med. Hyg. 1992;86:289
  15. Chippaux JP, Boussinesq J, Gardon J, Gardon-Wendel N, Ernould JC. Severe adverse reaction risks during mass treatment with ivermectin in loiasis-endemic areas. Parasitol. Today. 1996;12:448–450
  16. Chippaux JP, Bouchité B, Boussinesq M, Ranque S, Baldet T, Demanou M. Impact of repeated large scale ivermectin treatments on the transmission of Loa loa. Trans. R. Soc. Trop. Med. Hyg. 1998;192:454–458
  17. Despommier D, Karapelou J. Parasite Life Cycle. fifth ed.. New York, NY: Springer-Verlag; 1987;
  18. Duong TH, Kombila M, Ferrer A, Buereau P, Gaxotte P, Richard-Lenoble D. Reduced Loa loa microfilaria count ten to twelve months after a single dose of ivermectin. Trans. R. Soc. Trop. Med. Hyg. 1997;91:592–593
  19. Dupont A, Zue-N’dong J, Pinder M. Common occurrence of amicrofilaraemic Loa loa filariasis within the endemic region. Trans. R. Soc. Trop. Med. Hyg. 1988;82:730
  20. Eddleston M, Pierini S, Wilkinson R. Oxford Handbook of Tropical Medicine. second ed.. Philadelphia, PA: Oxford University Press; 2005;
  21. El Haouri M, Erragragui Y, Sbai M, Alioua Z, Louzi , El Mellouki W, et al. Cutaneous filariasis Loa loa: 26 Moroccan cases of importation. Ann. Dermatol. Venereol. 2001;128:899–902[in French]
  22. Esum M, Wanji S, Tendogfor N, Enyoung P. Co-endemicity of loiasis and onchocerciasis in the South West Province of Cameroon: implications for mass treatment with ivermectin. Trans. R. Soc. Trop. Med. Hyg. 2001;95:673–677
  23. Faust E, Russell P, Jung R. Craig and Faust's Clinical Parasitology. eighth ed.. Philadelphia, PA: Lea and Fabiger; 1997;
  24. Garcia A, Abel L, Cot M, Richard P, Ranque S, Feingold J, et al. Genetic epidemiology of host predisposition microfilaraemia in human loiasis. Trop. Med. Int. Health. 1999;4:565–574
  25. Gardon J, Kamgno J, Folefack G, Gardon-Wendel N, Bouchité B, Boussinesq M. Marked decrease in Loa loa microfilaraemia six and twelve months after a single dose of ivermectin. Trans. R. Soc. Trop. Med. Hyg. 1997;91:593–594
  26. Gardon J, Gardon-Wendel N, Ngangue D, Kamgno J, Chippaux J, Boussinesq M. Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection. Lancet. 1997;350:18–22
  27. Heelan J, Ingersoll F. Essentials of Human Parasitology. Albany, NY: Delmar; 2002;
  28. In:  Heymann D editors. Control of Communicable Diseases Manual. eighteenth ed.. Washington DC: American Public Health Association; 2004;
  29. Kamgno J, Boussinesq M. Hyperendemic loaiasis in the Tikar plain, shrub savanna region of Cameroon. Bull. Soc. Pathol. Exot. 2001;94:342–346[in French]
  30. Kamgno J, Bouchité B, Baldet T, Folefack G, Godin C, Boussinesq M. Study of the distribution of human filariasis in West Province of Cameroon. Bull. Soc. Pathol. Exot. 1997;90:327–330[in French]
  31. Kamgno J, Pion SD, Tejiokem MC, Twum-Danso NA, Thylefors B, Boussinesq M. Randomized, controlled, double-blind trial with ivermectin on Loa loa microfilaraemia: efficacy of a low dose (approximately 25μg/kg) versus current standard dose (150μg/kg). Trans. R. Soc. Trop. Med. Hyg. 2007;101:777–785
  32. Kean B, Mott K, Russell A. Tropical Medicine and Parasitology: classic investigations. New York, NY: Cornell University Press; 1978;
  33. Kemp C, Roberts A. Infectious diseases: filariasis, Malayan filariasis, loiasis (Loa loa), onchocerciasis (river blindness). J. Am. Acad. Nurse Pract. 2001;13:391–394
  34. Klion AD, Vijaykumar A, Oei T, Martin B, Nutman TB. Serum immunoglobulin G4 antibodies to the recombinant antigen, L1-SXP-1, are highly specific for Loa loa infection. J. Infect. Dis. 2003;187:128–133
  35. Lee L, Paton N. Importation of seven cases of an unusual helminthic infection into Singapore and assessment of the risk of local transmission. Singapore Med. J. 2004;45:227–228
  36. Lipner EM, Law MA, Barnett E, Keyston JS, von Sonnenburg F, Loutan L, et al. Filariasis in travelers presenting to the GeoSentinel Surveillance Network. PLoS Negl. Trop. Dis. 2007;1:e88
  37. Martin-Prevel Y, Cosnefroy JY, Ngari P, Pinder M. Reduction of microfilaraemia with single high-dose of ivermectin in loiasis. Lancet. 1993;342:442
  38. Noireau F, Carme B, Apembet JD, Gouteux JP. Loa loa and Mansonella perstans filariasis in the Chaillu mountains, Congo: parasitological prevalence. Trans. R. Soc. Trop. Med. Hyg. 1989;83:529–534
  39. Omura S, Crump A. The life and times of ivermectin—a success story. Nat. Rev. Microbiol. 2004;2:984–989
  40. Pion S, Gardon J, Kamgno J, Gardon-Wendel N, Chippaux J, Boussinesq M. Structure of the microfilarial reservoir of Loa loa in the human host and its implications for monitoring the programmes of community-directed treatment with ivermectin carried out in Africa. Parasitology. 2004;129:613–626
  41. Pion S, Demanou M, Oudin B, Boussinesq M. Loiasis: the individual factors associated with the presence of microfilaraemia. Ann. Trop. Med. Parasitol. 2005;99:491–500
  42. Pion SD, Filipe JA, Kamgno J, Gardon J, Basáñez MG, Boussinesq M. Microfilarial distribution of Loa loa in the human host: population dynamics and epidemiological implications. Parasitology. 2006;133:101–109
  43. Pion SD, Clarke P, Filipe JA, Kamgno J, Gardon J, Basáñez MG, et al. Co-infection with Onchocerca volvulus and Loa loa microfilariae in central Cameroon: are these two species interacting?. Parasitology. 2006;132:843–854
  44. Ranque S, Garcia A, Boussinesq M, Gardon J, Kamgno J, Chippaux JP. Decreased prevalence and intensity of Loa loa infection in a community treated with ivermectin every three months for two years. Trans. R. Soc. Trop. Med. Hyg. 1996;90:429–430
  45. In:  Resh V,  Cardé R editor. Encyclopedia of Insects.. San Diego, CA: Academic Press; 2003;
  46. Tabi TE, Befidi-Mengue R, Nutman TB, Hotron J, Folefack A, Pensia E, et al. Human loiasis in a Cameroonian village: a double-blind, placebo-controlled, crossover clinical trial of a three-day albendazole regimen. Am. J. Trop. Med. Hyg. 2004;71:211–215
  47. Takougang I, Meremikwu M, Wanji S, Yenshu EV, Aripko B, Lamlenn SB, et al. Rapid assessment method for prevalence and intensity of Loa loa infection. Bull. World Health Organ. 2002;80:852–858
  48. Takougang I, Meli J, Lamlenn S, Tatah P, Ntep M. Loiasis—a neglected and under-estimated affliction: endemicity, morbidity and perceptions in eastern Cameroon. Ann. Trop. Med. Parasitol. 2007;101:151–160
  49. Thomson MC, Obsomer V, Kamgno J, Gardon J, Wanji S, Takougang I, et al. Mapping the distribution of Loa loa in Cameroon in support of the African Programme for Onchocerciasis Control. Filaria J. 2004;3:7
  50. Touré FS, Egwang TG, Millet P, Bain O, Georges AJ, Wahl G. IgG4 serology of loiasis in three villages in an endemic area of south-eastern Gabon. Trop. Med. Int. Health. 1998;4:313–317
  51. Touré FS, Mavoungou E, Deloron P, Egwang TG. Comparative analysis of 2 diagnostic methods of human loiasis: IgG4 serology and nested PCR. Bull. Soc. Pathol. Exot. 1999;2:167–170[in French]
  52. Twum-Danso NA. Serious adverse events following treatment with ivermectin for onchocerciasis control: a review of reported cases. Filaria J. 2003;2(Suppl. 1):S3
  53. Ufomadu GO, Nwoke BE, Akoh JI, Sato A, Ekejindu GO, Uchida A, et al. The occurrence of loiasis, mansonellosis and wuchereriasis in the Jarawa River Valley, Central Nigeria. Acta Trop. 1991;48:137–147
  54. Van Hoegaerden M, Ivanoff B. The use of mebendazole in the treatment of filariases due to Loa loa and Mansonella perstans. Ann. Trop. Med. Parasitol. 1987;81:275–282
  55. Van Hoegaerden M, Chabaud B, Akue JP, Ivanoff B. Filariasis due to Loa loa and Mansonella perstans: distribution in the region of Okondja, Haut-Ogooué Province, Gabon, with parasitological and serological follow-up over one year. Trans. R. Soc. Trop. Med. Hyg. 1987;81:441–446
  56. Vila Montlleo R. Serum filariasis due to Loa loa and Mansonella perstans in the continental area of equatorial Guinea. Preliminary results. Med. Trop. (Mars.). 1990;50:399–402[in French]
  57. Wanji S, Tendongfor N, Esum M, Enyong P. Chrysops silacea biting densities and transmission potential in an endemic area of human loiasis in south-west Cameroon. Trop. Med. Int. Health. 2002;7:371–377
  58. Wanji S, Tendongfor N, Esum M, Atanga SN, Enyong P. Heterogeneity in the prevalence and intensity of loiasis in five contrasting bioecological zones in Cameroon. Trans. R. Soc. Trop. Med. Hyg. 2003;97:183–187
  59. Wanji S, Tendongfor N, Esum M, Ndindeng S, Enyong P. Epidemiology of concomitant infections due to Loa loa, Mansonella perstans, and Onchocerca volvulus in rain forest villages of Cameroon. Med. Microbiol. Immunol. 2003;192:15–21
  60. Wanji S, Tendongfor N, Esum M, Yundze SS, Taylor MJ, Enyong P. Combined utilisation of rapid assessment procedures for loiasis (RAPLOA) and onchocerciasis (REA) in rain forest villages of Cameroon. Filaria J. 2005;4:2

PII: S0035-9203(08)00143-0

doi: 10.1016/j.trstmh.2008.03.022

Transactions of the Royal Society of Tropical Medicine and Hygiene
Volume 102, Issue 10 , Pages 983-989 , October 2008

Article Tools

* Image Usage & Resolution